Trial Profile
Evaluation of the effects of pregabalin in essential tremor: A randomized, double-blind, placebo-controlled, crossover clinical trial [EVALUACION DE LOS EFECTOS DE LA PREGABALINA EN EL TEMBLOR ESENCIAL: ENSAYO CLINICO CRUZADO, RANDOMIZADO A DOBLE CIEGO Y CONTROLADO CON PLACEBO]
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Mar 2012
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Essential tremor
- Focus Therapeutic Use
- 29 Mar 2012 Planned End Date changed from 28 Nov 2009 to 28 Nov 2015 as reported in Eudra record.
- 31 Aug 2011 New trial record